Objectives: In vitro and in vivo activity of the dihydroorotate dehydrogenase inhibitor olorofim (formerly F901318) (F2G Limited, UK) against clinically relevant species of the Aspergillus section Terrei was evaluated.
Methods: A total of 92 clinical Aspergillus section Terrei isolates [42 Aspergillus terreus sensu stricto and 50 cryptic species: Aspergillus alabamensis (n = 8), Aspergillus citrinoterreus (n = 27), Aspergillus floccosus (n = 1), Aspergillus hortai (n = 13) and Aspergillus neoafricanus (n = 1)] were evaluated. MICs were determined using the CLSI M38-A2 method. MICs of olorofim were compared with those of posaconazole, voriconazole, itraconazole and amphotericin B. The in vivo efficacy of olorofim was determined in an immunosuppressed murine model of disseminated aspergillosis.
Results: Olorofim was highly active against all tested Aspergillus section Terrei isolates, exhibiting an MIC range of 0.002-0.063 mg/L. Slightly higher MICs were observed for A. terreus cryptic species. Olorofim MICs were lower than those observed for the azoles. Selected strains with elevated MICs of azoles were highly susceptible to olorofim. Olorofim administered by oral and intravenous routes produced survival rates of 90%-100% in A. terreus-infected mice.
Conclusions: Olorofim showed potent and consistent in vitro activity against all A. terreus strains tested, including those with elevated MICs of other antifungal substances. Overall, growth inhibition by olorofim was superior to that of azoles. In vivo data showed that olorofim was highly efficacious in prolonging survival of mice with disseminated aspergillosis due to A. terreus sensu stricto.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1093/jac/dky329 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Evaluation of the Activity of Triazoles Against Non- and Cryptic Species Causing Invasive Infections Tested in the SENTRY Program.
Open Forum Infect Dis
November 2024
JMI Laboratories, North Liberty, Iowa, USA.
Article Synopsis
- The study evaluated the effectiveness of isavuconazole and other triazoles against 390 non-AFM isolates causing invasive aspergillosis, collected from 41 hospitals between 2017-2021.
- Isavuconazole demonstrated significant antifungal activity, with minimum inhibitory concentrations (MIC) ranging from ≤0.12 to 2 mg/L across different sections of isolates, while some isolates exhibited elevated MIC values.
- Overall, isavuconazole showed potent in vitro activity against non-AFM fungi, though effectiveness varied among and within cryptic species, similar to other triazoles like voriconazole and posaconazole.
High Prevalence of Azole-Resistant Aspergillus fumigatus Among Iranian Cystic Fibrosis Patients: Should We Be Concerned?
Mycoses
September 2024
Department of Molecular Microbiology & Immunology, South Texas Center for Emerging Infectious Diseases, The University of Texas at san Antonio, San Antonio, Texas, USA.
Article Synopsis
- - The study investigates the prevalence of azole-resistant Aspergillus fumigatus (ARAf) in Iranian cystic fibrosis (CF) patients, noting that although common fungal infections include Candida species, ARAf poses a significant risk for severe lung infections.
- - Researchers collected and analyzed 120 sputum samples from 103 CF patients, finding that 84.2% were positive for filamentous fungi, with the majority being Aspergillus species and a smaller percentage being Candida species.
- - Among the Aspergillus isolates, 46.5% belonged to the Fumigati section, and 14 showed resistance to azole antifungals, indicating a 9% prevalence of ARAf in the total fungal
in the Indoor Air of Critical Areas of a Tertiary Hospital in Brazil.
J Fungi (Basel)
August 2024
Graduate Program in Infectious and Parasitic Diseases, Faculty of Medicine, Federal University of Mato Grosso do Sul, Campo Grande 79070-900, MS, Brazil.
Airborne spp. are critical pathogens that cause nosocomial infections in hospitals. Despite their importance, little is known about the distribution of species in the indoor air of hospitals in Brazil.
View Article and Find Full Text PDFGenomic Analysis of Section Reveals a High Potential in Secondary Metabolite Production and Plant Biomass Degradation.
J Fungi (Basel)
July 2024
Department of Biotechnology and Bioengineering, Technical University of Denmark, 2800 Kongens Lyngby, Denmark.
Article Synopsis
- The text discusses industrial biotechnology applications, focusing on the production of itaconic acid and bioactive metabolites from specific fungal species.
- Draft genome sequences were presented for multiple species, revealing a rich diversity of secondary metabolism genes, particularly in one genus, which shows high potential for genome mining.
- The study found unique strategies for UV protection among these species and highlighted their impressive ability to degrade plant polysaccharides, indicating further biotechnological uses.
Isolation of azole-resistant Aspergillus spp. from food products.
Med Mycol
March 2024
Department of Microbiology, Tokyo Metropolitan Insitute of Public Health, 3-24-1 Hyakunin-cho, Shinjuku-ku,Tokyo, Japan.
Article Synopsis
- The study investigates the rising global issue of azole-resistant Aspergillus fumigatus, which may be linked to the use of azole pesticides, particularly in food products.
- Researchers isolated 99 strains of Aspergillus spp. from 692 food samples, identifying various species, with a focus on the predominant types such as A. fumigatus and A. welwitschiae.
- Some strains showed resistance to azoles, suggesting that food contamination with Aspergillus spp. could pose health risks and highlighting the need for further research on the connection between food, environment, and these fungi.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!